Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 3Recruiting 2Withdrawn 1Approved for marketing 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 12Neoplasm, Residual 2Myeloproliferative Disorders 2Leukemia, Promyelocytic, Acute 2Sarcoma, Myeloid 1Recurrence 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Tretinoin 3Arsenic Trioxide 3Gemtuzumab 2arsenous acid 1Magnetic Resonance Spectroscopy 1Gadolinium 1Fluorodeoxyglucose F18 1Arsenic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Promyelocytic, Acute × Gemtuzumab × Clear all
NCT01409161 2026-05-20

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

M.D. Anderson Cancer Center

Phase 2 Recruiting
151 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT04793919 2024-04-15

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia

Associazione Italiana Ematologia Oncologia Pediatrica

Phase 2 Recruiting
89 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡